Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Equity (2021 - 2025)

Biofrontera (BFRI) has 5 years of Return on Equity data on record, last reported at 4.85% in Q3 2025.

  • For Q3 2025, Return on Equity rose 641.0% year-over-year to 4.85%; the TTM value through Sep 2025 reached 4.85%, up 641.0%, while the annual FY2024 figure was 3.85%, 245.0% down from the prior year.
  • Return on Equity reached 4.85% in Q3 2025 per BFRI's latest filing, down from 7.96% in the prior quarter.
  • Across five years, Return on Equity topped out at 74.13% in Q1 2024 and bottomed at 22.39% in Q2 2021.
  • Average Return on Equity over 5 years is 2.49%, with a median of 1.53% recorded in 2022.
  • Peak YoY movement for Return on Equity: skyrocketed 7480bps in 2024, then crashed -7880bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 12.48% in 2021, then tumbled by -100bps to 0.03% in 2022, then crashed by -24969bps to 6.9% in 2023, then soared by 48bps to 3.56% in 2024, then skyrocketed by 236bps to 4.85% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 4.85% in Q3 2025, 7.96% in Q2 2025, and 4.67% in Q1 2025.